ArriVent BioPharma, Inc. Common Stock

General ticker "AVBP" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $708.7M (TTM average)

ArriVent BioPharma, Inc. Common Stock follows the US Stock Market performance with the rate: 37.9%.

Estimated limits based on current volatility of 2.5%: low 26.14$, high 27.46$

Factors to consider:

  • Total employees count: 40 as of 2023
  • Price in estimated range
  • Earnings for 3 months up through Q1 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [13.67$, 29.02$]
  • 2026-12-31 to 2027-12-31 estimated range: [10.93$, 24.30$]

Financial Metrics affecting the AVBP estimates:

  • Negative: with PPE of -4.9 at the end of fiscal year the price was high
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of -19.29 <= 0.02
  • Negative: negative Net income
  • Negative: negative Industry operating cash flow (median)
  • Positive: Interest expense per share per price, % of 0 <= 0.01
  • Negative: Industry earnings per price (median), % of -12.76 <= 0
  • Positive: -14.22 < Investing cash flow per share per price, % of -8.56

Similar symbols

Short-term AVBP quotes

Long-term AVBP plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $74.59MM $94.31MM $177.53MM
Operating Income $-74.59MM $-94.31MM $-177.53MM
Non-Operating Income $5.26MM $13.82MM $11.23MM
R&D Expense $64.88MM $79.00MM $153.35MM
Income(Loss) $-69.33MM $-80.49MM $-166.31MM
Profit(Loss)* $-69.33MM $-80.49MM $-166.31MM
Stockholders Equity $-153.19MM $257.65MM $307.22MM
Assets $163.10MM $274.94MM $333.17MM
Operating Cash Flow $-55.84MM $-70.21MM $-160.59MM
Investing Cash Flow $0.00MM $-192.47MM $-71.23MM
Financing Cash Flow $42.86MM $186.58MM $203.06MM
Earnings Per Share** $-2.17 $-2.56 $-4.32

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.